Piramal Pharma Limited (PPLPHARMA.NS) NSE

177.00

-1.01(-0.57%)

Updated at December 24 03:29PM

Currency In INR

Valuation

Market Cap302.24B
Enterprise Value345.79B
P/E Ratio-986.61
PEG Ratio7.94
Price/Sales Ratio2.63
Price/Book Ratio2.9
Enterprise/Revenue3.11
Enterprise/EBITDA21.25

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0
Operating Margin0.37

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue91.51B
Revenue/Share67.65
Gross Profit59.2B
EBITDA14.04B
Net Income911.3M
Diluted EPS0.68

Balance Sheet

Total Cash7.44B
Total Cash/Share5.63
Total Debt48.51B
Total Debt/Equity0.6
Current Ratio1.43
Book Value Per Share61.12

Price History

52-Week Change-30.47
52-Week High273.35
52-Week Low165.12
Moving Average 50 Days188.23
Moving Average 200 Days200.43

Statistics

Average Volume3.28M
Shares Outstanding1.32B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.14
Trailing Annual Dividend Yield0.08
Payout Ratio0
Last Split Factor1023:1000
Last Split DateAugust 02, 2023